Eqis Capital Management, Inc. Amarin Corp Plcuk Transaction History

Eqis Capital Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.85 - $1.43 $11,943 - $20,092	-14,051 Reduced 41.63%	19,702 $18,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.49 $55,490 - $73,822	-49,545 Reduced 59.48%	33,753 $40,000
Q1 2023 May 15, 2023	BUY	$1.19 - $2.19 $99,124 - $182,422	83,298 New	83,298 $124,000
Q4 2020 Feb 11, 2021	SELL	$4.04 - $5.31 $177,384 - $233,146	-43,907 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$3.64 - $7.76 $159,821 - $340,718	43,907 New	43,907 $185,000
Q2 2020 Aug 10, 2020	SELL	$4.78 - $8.26 $583,093 - $1.01 Million	-121,986 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$4.0 - $21.53 $27,496 - $147,997	-6,874 Reduced 5.33%	121,986 $2.15 Million
Q4 2019 Jan 24, 2020	BUY	$13.94 - $24.12 $1.8 Million - $3.11 Million	128,860 New	128,860 $2.76 Million
Q2 2019 Jul 18, 2019	SELL	$16.27 - $20.51 $669,071 - $843,432	-41,123 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$12.61 - $22.33 $518,561 - $918,276	41,123 New	41,123 $854,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.